Personalized medicine in hepatitis C: From genome-wide association studies to clinical practice

Authors

  • Hermann E. Wasmuth M.D.,

    1. Department of Medicine III, Aachen, Germany
    2. Institute of Clinical Chemistry and Pathobiochemistry, University Hospital Aachen, Aachen, Germany
    Search for more papers by this author
  • Ralf Weiskirchen Ph.D.

    1. Department of Medicine III, Aachen, Germany
    2. Institute of Clinical Chemistry and Pathobiochemistry, University Hospital Aachen, Aachen, Germany
    Search for more papers by this author

  • Work in the laboratories of Hermann E. Wasmuth and Ralf Weiskirchen is supported by the Deutsche Forschungsgemeinschaft (SFB-TRR 57) and the Interdisziplinäres Zentrum für Klinische Forschung of the Medical Faculty of Aachen (to Hermann E. Wasmuth).

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary